Investor's Business Daily5h agoCG Oncology Exceeds Even the 'Most Bullish Conversations' as Shares Break OutCG Oncology said its experimental therapy reduced the risk of bladder cancer recurrence by 68%. Its shares broke out. SourceDisclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.Stocks